An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies

An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies

This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies

Older adults with hematologic malignancies receive more aggressive inpatient care at the end of life compared to patients with solid tumors. Advance care planning may promote early serious illness conversations for patients with hematologic malignancies, leading to less aggressive healthcare utilization at the end of life. This pilot aims to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies.

Inclusion Criteria:

• Age ≥60 years
• A diagnosis of hematologic malignancy [including but not limited to acute leukemia, myeloid malignancies (e.g., atypical CML, MDS/MPN overlap syndromes, CMML), multiple myeloma, lymphoma, or any other hematologic malignancies based on the primary oncologist's judgment]
• Able to provide informed consent
• Being managed in the inpatient setting
• English-speaking

Exclusion Criteria:

• None